Gene · 26952
SMR3A: submaxillary gland androgen regulated protein 3A
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SMR3A: submaxillary gland androgen regulated protein 3A. Genes, record 26952. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/26952
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q99954 | Submaxillary gland androgen-regulated protein 3A | 134 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 667 | Q99954 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 467 | Q99954 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 12606 | Q99954 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 1855 | Q99954 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7760 | Q99954 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7760 | Q99954 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 467 | Q99954 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 667 | Q99954 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 12606 | Q99954 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 12606 | Q99954 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants906
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SMR3A papers | Newest fiscal year |
|---|---|---|---|
| P30CA021765 | Cancer Center Support Grant (CCSG) | 6 | 2025 |
| R37AI101935 | Inflammatory Caspases in Innate Immunity and Inflammation | 5 | 2025 |
| T32AI007647 | Training Program in Mechanisms of Virus-Host Interactions | 5 | 2025 |
| P51OD011106 | Wisconsin National Primate Research Center Support | 4 | 2025 |
| R01AI124346 | Innate immune signaling and stress response | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 3 | 2025 |
| P30CA056036 | Translational Research in Cancer | 3 | 2025 |
| R01GM108998 | Structural and Functional Studies of Protein Kinase C Regulation | 3 | 2025 |
| R35GM122523 | Molecular Mechanisms of Cell Signaling | 3 | 2025 |
1 to 10 of 906Source NIH's project files
See all 906 nih grantsPapers1,866
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Reassortant H9N2 Avian Influenza Viruses with Dual Receptor-Binding Capacity and Evidence of Direct Mammalian Infectivity Circulating in Northeast China Live Poultry Markets. | Viruses | 2026 | 42515623 | PubTator, text mining | PubMed |
| Coupled Transport, Plasticization, and Retention Mechanisms in Phosphoric Acid-Doped PBI Membranes. | Membranes (Basel) | 2026 | 42346966 | PubTator, text mining | PubMed |
| HVIface: sequence-based deep learning for decoding human-virus protein-protein interfaces. | Front Bioinform | 2026 | 42181034 | PubTator, text mining | PubMed |
| Gga-miR-449c suppresses H9N2 influenza virus replication via targeting the viral genome and suppressor of cytokine signaling 3. | Int J Biol Macromol | 2026 | 42128110 | PubTator, text mining | PubMed |
| Abstracts from The XXV Brazilian Diabetes Society Meeting. | Diabetol Metab Syndr | 2026 | 41913261 | PubTator, text mining | PubMed |
| Identification and Structural Elucidation of Galloylated B-Type Procyanidins From Rumex obtusifolius L. Using Enzymatic Digestion, Phloroglucinolysis, and High-Resolution Mass Spectrometry. | J Sep Sci | 2026 | 41906417 | PubTator, text mining | PubMed |
| Spatial Transcriptomics Meets Histochemistry: Insights from Glioblastoma as a Model System. | Acta Histochem Cytochem | 2026 | 41810324 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation in neural development. | Cell Mol Life Sci | 2026 | 41790295 | PubTator, text mining | PubMed |
| The roles of post-translational modifications in the pathogenesis of RNA viruses: allies or adversaries? | Front Microbiol | 2026 | 41767575 | PubTator, text mining | PubMed |
| Dissecting Cell Death Pathways in Influenza A Virus Infection: Comparative Insights from Human Models. | Viruses | 2026 | 41754589 | PubTator, text mining | PubMed |
1 to 10 of 1,866
See all 1,866 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/26952
GET https://conductscience.org/api/genes/v1/26952/patents?page=2